ArticleRSC advances2020
Graphene oxide-iridium nanocatalyst for the transformation of benzylic alcohols into carbonyl compounds.
Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 9 citations in OpenAlex.
- Iridium/graphene nanostructured catalyst for theRSC advances · 2022Article
- La(OH)RSC advances · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A catalyst constructed from graphene oxide and iridium chloride exhibited high activity and reliability for the selective transformation of benzylic alcohols into aromatic aldehydes or ketones. Instead of thermal reaction, the transformation was performed under ultrasonication, a green process with low byproduct, high atomic yield and high selectivity. Experimental data obtained from spherical-aberration corrected field emission TEM (ULTRA-HRTEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy and Raman spectra confirm the nanostructure of the title complex. Noticeably, the activity and selectivity for the transformation of benzylic alcohols remained unchanged within 25 catalytic cycles. The average turn over frequency is higher than 5000 h
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.